nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—trigeminal nucleus—multiple sclerosis	0.23	0.323	CbGeAlD
Remoxipride—HTR2A—trigeminal nerve—multiple sclerosis	0.0603	0.0849	CbGeAlD
Remoxipride—HTR2A—pons—multiple sclerosis	0.0424	0.0598	CbGeAlD
Remoxipride—DRD2—nerve—multiple sclerosis	0.0334	0.047	CbGeAlD
Remoxipride—HTR2A—pineal body—multiple sclerosis	0.0303	0.0427	CbGeAlD
Remoxipride—HTR2A—peripheral nervous system—multiple sclerosis	0.0282	0.0398	CbGeAlD
Remoxipride—Sulpiride—BCHE—multiple sclerosis	0.0247	1	CrCbGaD
Remoxipride—HTR2A—nerve—multiple sclerosis	0.022	0.031	CbGeAlD
Remoxipride—DRD4—brain—multiple sclerosis	0.0193	0.0272	CbGeAlD
Remoxipride—DRD3—nervous system—multiple sclerosis	0.0177	0.025	CbGeAlD
Remoxipride—DRD3—central nervous system—multiple sclerosis	0.0171	0.0241	CbGeAlD
Remoxipride—DRD2—brainstem—multiple sclerosis	0.0143	0.0202	CbGeAlD
Remoxipride—DRD2—retina—multiple sclerosis	0.0138	0.0195	CbGeAlD
Remoxipride—DRD3—brain—multiple sclerosis	0.0136	0.0191	CbGeAlD
Remoxipride—SIGMAR1—medulla oblongata—multiple sclerosis	0.0124	0.0174	CbGeAlD
Remoxipride—SIGMAR1—midbrain—multiple sclerosis	0.0113	0.0159	CbGeAlD
Remoxipride—SIGMAR1—spinal cord—multiple sclerosis	0.011	0.0155	CbGeAlD
Remoxipride—HTR2A—brainstem—multiple sclerosis	0.00945	0.0133	CbGeAlD
Remoxipride—DRD2—midbrain—multiple sclerosis	0.00913	0.0129	CbGeAlD
Remoxipride—HTR2A—retina—multiple sclerosis	0.00912	0.0128	CbGeAlD
Remoxipride—SIGMAR1—cerebellum—multiple sclerosis	0.00875	0.0123	CbGeAlD
Remoxipride—CYP2D6—brainstem—multiple sclerosis	0.00861	0.0121	CbGeAlD
Remoxipride—DRD2—nervous system—multiple sclerosis	0.00751	0.0106	CbGeAlD
Remoxipride—DRD2—central nervous system—multiple sclerosis	0.00723	0.0102	CbGeAlD
Remoxipride—SIGMAR1—brain—multiple sclerosis	0.0071	0.01	CbGeAlD
Remoxipride—DRD2—cerebellum—multiple sclerosis	0.00706	0.00995	CbGeAlD
Remoxipride—HTR2A—medulla oblongata—multiple sclerosis	0.00659	0.00929	CbGeAlD
Remoxipride—HTR2A—midbrain—multiple sclerosis	0.00602	0.00849	CbGeAlD
Remoxipride—HTR2A—spinal cord—multiple sclerosis	0.00588	0.00828	CbGeAlD
Remoxipride—DRD2—brain—multiple sclerosis	0.00574	0.00809	CbGeAlD
Remoxipride—HTR2A—nervous system—multiple sclerosis	0.00495	0.00698	CbGeAlD
Remoxipride—HTR2A—central nervous system—multiple sclerosis	0.00477	0.00672	CbGeAlD
Remoxipride—HTR2A—cerebellum—multiple sclerosis	0.00466	0.00657	CbGeAlD
Remoxipride—CYP2D6—nervous system—multiple sclerosis	0.00451	0.00636	CbGeAlD
Remoxipride—CYP2D6—central nervous system—multiple sclerosis	0.00434	0.00612	CbGeAlD
Remoxipride—CYP2D6—cerebellum—multiple sclerosis	0.00424	0.00598	CbGeAlD
Remoxipride—HTR2A—brain—multiple sclerosis	0.00378	0.00533	CbGeAlD
Remoxipride—CYP2D6—brain—multiple sclerosis	0.00345	0.00486	CbGeAlD
Remoxipride—HTR2A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000336	0.00127	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000335	0.00126	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCR3—multiple sclerosis	0.000333	0.00125	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CNR1—multiple sclerosis	0.000329	0.00124	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000326	0.00123	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GPR65—multiple sclerosis	0.000325	0.00122	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR2—multiple sclerosis	0.000324	0.00122	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL3—multiple sclerosis	0.000318	0.0012	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—POMC—multiple sclerosis	0.000318	0.0012	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000317	0.00119	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TAGAP—multiple sclerosis	0.000313	0.00118	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL2—multiple sclerosis	0.000311	0.00117	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TAGAP—multiple sclerosis	0.000308	0.00116	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL5—multiple sclerosis	0.000307	0.00116	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000306	0.00115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RGS1—multiple sclerosis	0.000304	0.00115	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL5—multiple sclerosis	0.000302	0.00114	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CNR1—multiple sclerosis	0.000299	0.00113	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL13—multiple sclerosis	0.000297	0.00112	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR1—multiple sclerosis	0.000297	0.00112	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000296	0.00112	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000296	0.00111	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000292	0.0011	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GPR65—multiple sclerosis	0.000288	0.00109	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000288	0.00109	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR2—multiple sclerosis	0.000288	0.00108	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000284	0.00107	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—POMC—multiple sclerosis	0.000282	0.00106	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000279	0.00105	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000278	0.00105	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCR5—multiple sclerosis	0.000276	0.00104	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL2—multiple sclerosis	0.000276	0.00104	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	0.000274	0.00103	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000273	0.00103	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000272	0.00102	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000269	0.00101	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL10—multiple sclerosis	0.000269	0.00101	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000267	0.00101	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GPC5—multiple sclerosis	0.000266	0.001	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CNR1—multiple sclerosis	0.000266	0.001	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL13—multiple sclerosis	0.000264	0.000993	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR1—multiple sclerosis	0.000264	0.000993	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000263	0.000991	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000262	0.000988	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	0.000262	0.000987	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—multiple sclerosis	0.000259	0.000974	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000258	0.000972	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCL5—multiple sclerosis	0.000255	0.000961	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000254	0.000956	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000249	0.000939	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000245	0.000923	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	0.000243	0.000917	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000242	0.000913	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	0.00024	0.000902	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000239	0.0009	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000239	0.000898	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000234	0.000882	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RGS1—multiple sclerosis	0.000233	0.000877	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL5—multiple sclerosis	0.000232	0.000872	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000231	0.000868	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCR5—multiple sclerosis	0.00023	0.000866	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—multiple sclerosis	0.00023	0.000865	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	0.000229	0.000863	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000227	0.000853	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000227	0.000853	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000226	0.000852	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000224	0.000843	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000223	0.000839	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GPR65—multiple sclerosis	0.000221	0.000831	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	0.00022	0.000829	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.00022	0.000829	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	0.000217	0.000818	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000217	0.000816	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—POMC—multiple sclerosis	0.000216	0.000814	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000213	0.000803	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	0.000213	0.000801	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000212	0.000797	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL3—multiple sclerosis	0.000212	0.000797	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	0.000211	0.000796	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR5—multiple sclerosis	0.000209	0.000786	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000208	0.000783	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL5—multiple sclerosis	0.000206	0.000775	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000206	0.000775	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000204	0.000769	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTGER4—multiple sclerosis	0.000204	0.000767	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	0.000203	0.000765	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	0.000203	0.000765	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	0.000203	0.000765	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR1—multiple sclerosis	0.000202	0.00076	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	0.000202	0.00076	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000201	0.000759	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000201	0.000758	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PGR—multiple sclerosis	0.000201	0.000755	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	0.0002	0.000753	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000199	0.000748	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	0.000199	0.000748	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000198	0.000746	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCR3—multiple sclerosis	0.000197	0.000741	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CD28—multiple sclerosis	0.000195	0.000734	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR2—multiple sclerosis	0.000191	0.000721	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL3—multiple sclerosis	0.000188	0.000708	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPC5—multiple sclerosis	0.000186	0.0007	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR5—multiple sclerosis	0.000185	0.000698	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000183	0.000689	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000183	0.000688	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTGER4—multiple sclerosis	0.000181	0.000681	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.00018	0.000678	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—POMC—multiple sclerosis	0.00018	0.000676	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PGR—multiple sclerosis	0.000178	0.000671	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CNR1—multiple sclerosis	0.000177	0.000665	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	0.000176	0.000662	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCR3—multiple sclerosis	0.000175	0.000658	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000173	0.000653	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CD28—multiple sclerosis	0.000173	0.000652	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000171	0.000643	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR2—multiple sclerosis	0.00017	0.00064	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000164	0.000617	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—POMC—multiple sclerosis	0.000163	0.000614	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL2—multiple sclerosis	0.00016	0.000601	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—POMC—multiple sclerosis	0.00016	0.000601	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL10—multiple sclerosis	0.000159	0.000599	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	0.000157	0.000593	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CNR1—multiple sclerosis	0.000157	0.000591	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000156	0.000588	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000155	0.000583	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000154	0.00058	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—RRM1—multiple sclerosis	0.000154	0.00058	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000154	0.000579	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000152	0.000571	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—TYK2—multiple sclerosis	0.000145	0.000546	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—POMC—multiple sclerosis	0.000145	0.000546	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL3—multiple sclerosis	0.000144	0.000542	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	0.000142	0.000534	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL2—multiple sclerosis	0.000142	0.000534	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	0.000142	0.000533	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL10—multiple sclerosis	0.000141	0.000532	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00014	0.000527	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	0.00014	0.000526	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CD86—multiple sclerosis	0.000139	0.000524	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	0.000138	0.000521	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000138	0.000518	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL5—multiple sclerosis	0.000137	0.000515	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PGR—multiple sclerosis	0.000136	0.000513	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000136	0.000513	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PGR—multiple sclerosis	0.000134	0.000505	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	0.000134	0.000503	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—IL2—multiple sclerosis	0.000133	0.0005	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD28—multiple sclerosis	0.000132	0.000499	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000132	0.000495	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD28—multiple sclerosis	0.00013	0.000491	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR2—multiple sclerosis	0.00013	0.00049	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—TYK2—multiple sclerosis	0.000129	0.000485	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	0.000128	0.000482	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SPP1—multiple sclerosis	0.000127	0.000477	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CD86—multiple sclerosis	0.000124	0.000465	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR5—multiple sclerosis	0.000123	0.000464	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	0.000122	0.00046	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL5—multiple sclerosis	0.000122	0.000458	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2RA—multiple sclerosis	0.000122	0.000458	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL2—multiple sclerosis	0.000121	0.000454	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	0.00012	0.000452	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CNR1—multiple sclerosis	0.00012	0.000452	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	0.000118	0.000445	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—IL2—multiple sclerosis	0.000118	0.000444	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SPP1—multiple sclerosis	0.000113	0.000424	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOE—multiple sclerosis	0.000112	0.000422	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—POMC—multiple sclerosis	0.000111	0.000418	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR5—multiple sclerosis	0.00011	0.000412	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	0.000109	0.000411	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	0.000109	0.000409	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	0.000108	0.000407	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2RA—multiple sclerosis	0.000108	0.000406	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL2—multiple sclerosis	0.000107	0.000403	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	0.000107	0.000402	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	0.000106	0.0004	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CD80—multiple sclerosis	0.000101	0.000382	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOE—multiple sclerosis	9.97e-05	0.000375	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	9.85e-05	0.000371	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	9.69e-05	0.000365	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—POMC—multiple sclerosis	9.64e-05	0.000363	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD86—multiple sclerosis	9.45e-05	0.000356	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL2—multiple sclerosis	9.43e-05	0.000355	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL5—multiple sclerosis	9.3e-05	0.00035	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD86—multiple sclerosis	9.3e-05	0.00035	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MAPK1—multiple sclerosis	9.23e-05	0.000347	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	9.15e-05	0.000345	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	9.03e-05	0.00034	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CD80—multiple sclerosis	9.01e-05	0.000339	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	8.88e-05	0.000334	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.84e-05	0.000333	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SPP1—multiple sclerosis	8.62e-05	0.000324	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TYK2—multiple sclerosis	8.56e-05	0.000322	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—POMC—multiple sclerosis	8.56e-05	0.000322	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	8.48e-05	0.000319	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR5—multiple sclerosis	8.38e-05	0.000316	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL2—multiple sclerosis	8.38e-05	0.000315	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	8.26e-05	0.000311	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	8.25e-05	0.000311	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—multiple sclerosis	8.2e-05	0.000309	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	8.2e-05	0.000309	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	8.13e-05	0.000306	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	8.07e-05	0.000304	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOE—multiple sclerosis	7.63e-05	0.000287	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TYK2—multiple sclerosis	7.61e-05	0.000286	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOE—multiple sclerosis	7.5e-05	0.000283	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—multiple sclerosis	7.13e-05	0.000268	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—multiple sclerosis	7.09e-05	0.000267	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD80—multiple sclerosis	6.89e-05	0.00026	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD80—multiple sclerosis	6.78e-05	0.000255	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—multiple sclerosis	6.74e-05	0.000254	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.55e-05	0.000247	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.45e-05	0.000243	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6.41e-05	0.000241	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—multiple sclerosis	6.33e-05	0.000238	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.31e-05	0.000237	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—multiple sclerosis	6.3e-05	0.000237	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.27e-05	0.000236	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.17e-05	0.000232	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—multiple sclerosis	6e-05	0.000226	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—multiple sclerosis	5.99e-05	0.000226	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TYK2—multiple sclerosis	5.82e-05	0.000219	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	5.73e-05	0.000216	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MYC—multiple sclerosis	5.57e-05	0.00021	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	5.56e-05	0.000209	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	5.45e-05	0.000205	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—multiple sclerosis	5.33e-05	0.000201	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOE—multiple sclerosis	5.32e-05	0.0002	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MYC—multiple sclerosis	4.95e-05	0.000186	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	4.94e-05	0.000186	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—multiple sclerosis	4.84e-05	0.000182	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	4.84e-05	0.000182	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—multiple sclerosis	4.82e-05	0.000181	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—multiple sclerosis	4.77e-05	0.000179	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	4.74e-05	0.000179	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.58e-05	0.000173	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—POMC—multiple sclerosis	4.57e-05	0.000172	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.51e-05	0.00017	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—multiple sclerosis	4.19e-05	0.000158	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—multiple sclerosis	4.17e-05	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.08e-05	0.000153	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.01e-05	0.000151	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MYC—multiple sclerosis	3.79e-05	0.000143	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	3.78e-05	0.000142	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.73e-05	0.00014	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—multiple sclerosis	3.72e-05	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.72e-05	0.00014	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-05	0.000139	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.65e-05	0.000137	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.85e-05	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.8e-05	0.000105	CbGpPWpGaD
